US 8247536
Factor VIII compositions
granted A61KA61K38/37A61K47/10
Quick answer
US patent 8247536 (Factor VIII compositions) held by Nektar Therapeutics expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K38/37, A61K47/10, A61K47/60, A61P